Literature DB >> 29065738

Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature.

Chuanbo Xie1, Wei Wang2, Xiuhong Li3, Nan Shao4, Weidong Li5.   

Abstract

OBJECTIVE: The association between gestational diabetes mellitus (GDM) and maternal breast cancer risk was controversial and inclusive. In this study, we aimed to examine the association between GDM and maternal breast cancer using meta-analysis method.
METHODS: Researchers searched and reviewed the topic related articles comprehensively. For each eligible article, we extracted the effect size (odds ratio/relative risk or OR/RR) and its 95% confidence interval (CI). We used random effect models to combine the effect sizes. Subgroups analysis were used to examine whether the effects of GDM on breast cancer risk differed across GDM ascertainment methods, breast cancer ascertainment method, risk of bias, and country of study origin.
RESULTS: Five case-control studies and six cohort studies which met the eligible criteria were included into analysis. Overall, we didn't find significant associations between GDM and breast cancer among case-control studies (pooled OR = 0.85, 95%CI = 0.65, 1.10) and cohort studies pooled RR = 1.00, 95%CI = 0.80, 1.25). However, our subgroup analysis showed that GDM was a protective factor for breast cancer among the case-control studies in which breast cancer was ascertained via cancer registry system (OR = 0.73, 95%CI = 0.54, 1.00).
CONCLUSIONS: GDM during pregnancy is not associated with breast cancer in our study, suggesting that GDM mothers are not needed to be too anxious about their future breast cancer risk.

Entities:  

Keywords:  Gestational diabetes mellitus; breast cancer; meta-analysis

Mesh:

Year:  2017        PMID: 29065738     DOI: 10.1080/14767058.2017.1397117

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

Review 1.  Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Authors:  Jiri Polivka; Irem Altun; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-02-08       Impact factor: 6.543

2.  Gestational Diabetes and Risk of Breast Cancer in African American Women.

Authors:  Kimberly A Bertrand; Nelsy Castro-Webb; Yvette C Cozier; Shanshan Li; Katie M O'Brien; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-21       Impact factor: 4.254

3.  Gestational diabetes and risk of breast cancer before age 55 years.

Authors:  Kimberly A Bertrand; Katie M O'Brien; Lauren B Wright; Julie R Palmer; William J Blot; A Heather Eliassen; Lynn Rosenberg; Sven Sandin; Deirdre Tobias; Elisabete Weiderpass; Wei Zheng; Anthony J Swerdlow; Minouk J Schoemaker; Hazel B Nichols; Dale P Sandler
Journal:  Int J Epidemiol       Date:  2022-01-06       Impact factor: 7.196

4.  Gestational diabetes and risk of breast cancer before age 55 years.

Authors:  Kimberly A Bertrand; Katie M O'Brien; Lauren B Wright; Julie R Palmer; William J Blot; A Heather Eliassen; Lynn Rosenberg; Sven Sandin; Deirdre Tobias; Elisabete Weiderpass; Wei Zheng; Anthony J Swerdlow; Minouk J Schoemaker; Hazel B Nichols; Dale P Sandler
Journal:  Int J Epidemiol       Date:  2022-01-06       Impact factor: 9.685

Review 5.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

Review 6.  Cancer Progress and Priorities: Breast Cancer.

Authors:  Serena C Houghton; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05       Impact factor: 4.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.